Further, US Federal Reserve chief Janet Yellen rekindled hopes of an interest rate hike in December stating growth in the US economy.
At 1:20pm, the 30-share Sensex was down 66 points at 26,486 and the 50-share Nifty was down 27 points at 8,013.
Also Read
The Indian rupee was trading lower against the US dollar at Rs 65.68 on the back of demand from importers for the US currency.
EARNINGS CORNER
Cipla, Novartis India, Tata Global Beverages and Tata Steel will unveil their second quarter earnings today.
GLOBAL MARKETS
Asian markets were trading mixed with shares in Japan and China gaining the most. Japan's Nikkei was up 1% while China's Shanghai gained 1.8%. However, Hang Seng was down 0.1% and Straits Times was down 0.3%.
European shares were also trading mixed with DAX stocks losing the most. CAC and FTSE were up 0.3-0.5% each while Germany's DAX was down nearly 1%.
SECTORS & STOCKS
BSE Bankex was the top loser down 1.2% followed by Healthcare and Realty among others.
Banks which are a proxy to the economy witnessed profit taking and were among the top losers. ICICI Bank, Axis Bank, HDFC Bank and SBI were down 0.7-2% each.
Metal shares were among the top losers with Vedanta, Tata Steel and Hindalco were down 1-3% each.
Vedanta Resources was down 3.2%. The company on Tuesday reported widening of its net loss to $324.5 million in the first half of the current financial year as the mining conglomerate faced challenging commodities market.
IT major TCS and pharma major Sun Pharma were also among the top Sensex losers,
Auto shares were up on hopes of higher sales during the ongoing festive season following the new model launches. M&M, Maruti Suzuki, Tata Motors and Hero MotoCorp were up 0.6-0.7% each. Tata Motors extended gains after encouraging JLR sales in the US.
Stocks such as Maruti Suzuki, Bank of Baroda, Ashok Leyland, Yes Bank, Indian Oil Corporation Ltd (IOCL) are likely to make an entry into in the MSCI India index as per Emkay, a research analyst firm.
Among others, shares of Yuken India were locked in 20% upper circuit at Rs 312 after the company said it has signed an agreement with Bangalore-based real estate developer Brigade Enterprises Ltd.
Morepen Laboratories has surged 16% to Rs 21.40, also its 52-week high on the NSE, after the company reported an over 10-fold jump in net profit at Rs 3.22 crore for the quarter ended September 30, 2015 (Q2), on back improvement in sales revenues.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
)